FBXW11 and ovarian cancer: To clarify whether the upregulation of FBXW11 contributes to olaparib-mediated killing or enhances olaparib tolerance in ovarian cancer cells, we silenced the expression of FBXW11 in these three cell lines using siRNA (Figs. 1D and E).